Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Hourigan

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Journal of Clinical Medicine|May 2, 2015
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid LeukemiaNestor R Ramos, Clifton C Mo, Judith E Karp, et al.
Leukemia & Lymphoma|March 1, 2013
Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphomaChristopher S Hourigan, Patrick M Forde, Richard F Ambinder, et al.
Leukemia Research Reports|July 9, 2014
Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemiaEnkhtsetseg Purev, Bogdan Dumitriu, Christopher S Hourigan, et al.
Leukemia|May 25, 2024
TP53 mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2024
<i>TP53</i> mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2019
Heterogeneity in refractory acute myeloid leukemiaSachi Horibata, Gege Gui, Justin Lack, et al.
Haematologica|September 2, 2018
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemiaLaura W Dillon, Sheida Hayati, Gregory W Roloff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
When the Minimal Becomes MeasurableChristopher S Hourigan, Meghali Goswami, Minoo Battiwalla, et al.
European Journal of Immunology|November 17, 2006
The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognitionChristopher S Hourigan, Maria Harkiolaki, Neil A Peterson, et al.
Clinical Hematology International|March 20, 2020
Timed sequential salvage chemotherapy for relapsed or refractory acute myeloid leukemiaBogdan Popescu, Sheenu Sheela, Julie Thompson, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Journal of Clinical Medicine|May 2, 2015
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid LeukemiaNestor R Ramos, Clifton C Mo, Judith E Karp, et al.
Leukemia & Lymphoma|March 1, 2013
Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphomaChristopher S Hourigan, Patrick M Forde, Richard F Ambinder, et al.
Leukemia Research Reports|July 9, 2014
Translocation (8;21) acute myeloid leukemia presenting as severe aplastic anemiaEnkhtsetseg Purev, Bogdan Dumitriu, Christopher S Hourigan, et al.
Leukemia|May 25, 2024
TP53 mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2024
<i>TP53</i> mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2019
Heterogeneity in refractory acute myeloid leukemiaSachi Horibata, Gege Gui, Justin Lack, et al.
Haematologica|September 2, 2018
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemiaLaura W Dillon, Sheida Hayati, Gregory W Roloff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
When the Minimal Becomes MeasurableChristopher S Hourigan, Meghali Goswami, Minoo Battiwalla, et al.
European Journal of Immunology|November 17, 2006
The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognitionChristopher S Hourigan, Maria Harkiolaki, Neil A Peterson, et al.
Clinical Hematology International|March 20, 2020
Timed sequential salvage chemotherapy for relapsed or refractory acute myeloid leukemiaBogdan Popescu, Sheenu Sheela, Julie Thompson, et al.
Pageof 15